In a recent study posted to the bioRxiv* pre-print server, researchers developed a novel high-throughput method to obtain monoclonal antibodies (mAbs) from convalescent coronavirus disease 2019 (COVID ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback